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Introduction
Hepatic natural killer (NK) cells, also known as pit cells,
are located in the liver sinusoids, adhering to the endothe-
lial cells (LSECs), and are thus in a strategic position to kill
arriving metastasizing tumor cells [1-3]. NK cells of differ-
ent tissue origin (blood, spleen, liver) appear to have dif-
ferent levels of cytotoxicity. Lower levels can be enhanced
by lymphokines such as interleukin-2 (IL-2) or IL-12, pro-
viding lymphokine-activated killer (LAK) cells [1]. P815
mastocytoma cells were found to be resistant to the induc-
tion of cytolysis (quantified by 51Cr release) by NK cells
from spleen or blood, but are sensitive to hepatic NK and
LAK cells [[1,3] and references therein]. Hepatic NK cells
therefore might be considered as naturally activated LAK
cells.
Cytotoxic lymphocytes (NK cells, LAK cells, cytotoxic T
cells, NK-T cells) use the FasL and the perforin/granzyme
pathway to kill target cells [3]. FasL on effector cells binds
Fas present on the target cell membrane, which results in
oligomerization of Fas and activation of caspase 8. Per-
forin and granzymes, of which granzyme B is the most
potent, reside in granules of the cytotoxic lymphocytes
and are released by exocytosis. Intracellular delivery of
granzyme B results in the initiation of the caspase cascade
by proteolytic activation of caspase 3, either directly [4] or
through a mitochondrium-dependent pathway [5]. Cas-
pases play a central role in the execution of apoptosis [4].
In this study, we investigated the mechanism hepatic NK
cells use to kill P815 cells.
Methods
P815, a mouse mastocytoma cell line, was maintained in
culture medium consisting of DMEM (42430, GIBCO,
Life Technologies, Belgium) supplemented with 10 %
fetal bovine serum (Eurobiochem, Bierges, Belgium),
sodium pyruvate (1 mmol/L), penicillin (100 U/ml),
streptomycin (100 U/ml), and L-glutamine (0.2 mmol/L)
(GIBCO, Life Technologies).
Hepatic NK cells were isolated from male Wistar rats
(Proefdierencentrum, K.U.L., Leuven, Belgium) of 12–16
weeks old weighing ca. 300 g, as described previously
[6,7].
Transmission electron microscopy (TEM) was per-
formed as described [8].
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Quantitative DNA fragmentation assay was performed
as described at an E/T ratio of 10/1 and 3 h co-incubation
[8].
51Cr release assay
Cytolysis was measured in a 4 h 51Cr release assay as
described previously [9]. DCI (3,4-dichloroisocoumarin)
and EGTA were purchased from ICN (Asse-Relegem, Bel-
gium) and Z-VAD-FMK (Z-Val-Ala-Asp(OMe)-fluor-
omethylketone) from Bachem (Bubendorf, Switzerland).
Results and Discussion
Hepatic NK cells induced nucleus condensation and frag-
mentation in P815 cells, as shown by fluorescent nuclear
staining (data not shown) and TEM (Fig. 1). Chromatin
was condensed into masses that abutted the inner surface
of the nuclear envelope and was accompanied by nuclear
fragmentation (Fig. 1). Using DNA fragmentation and
51Cr release we verified that hepatic and not splenic NK
cells kill P815 cells [8].
We showed that P815 cells are sensitive to both the FasL
and perforin/granzyme pathway and hepatic NK cells
express FasL, perforin and granzyme B [8]. Several
approaches, distinguishing the FasL and perforin/
granzyme pathway, were used to determine how hepatic
Hepatic NK cells induce apoptosis in P815 cells as shown by TEM Figure 1
Hepatic NK cells induce apoptosis in P815 cells as shown by TEM. P815, P815 cells in medium only; P815+H-NK, P815 cells 
coincubated for 3 h with hepatic NK cells at an E/T ratio of 10/1. When P815 cells are coincubated with hepatic NK cells (thin 
arrow), nuclei of P815 cells become condensed and fragmented (thick arrow). Note the granules present in the hepatic NK 
cells (arrowhead). Bar: 1 µm. (From reference 8, with permission.)
The effect of inhibitory compounds on the killing of P815  cells by hepatic NK cells as determined by DNA fragmenta- tion and 51Cr release Figure 2
The effect of inhibitory compounds on the killing of P815 
cells by hepatic NK cells as determined by DNA fragmenta-
tion and 51Cr release. CON, control; EGTA, 5 mmol/L EGTA 
present during coincubation; DCI, preincubation of hepatic 
NK cells with 50 micromolar/L DCI for 30 minutes, no DCI 
present during coincubation; VAD, preincubation of P815 
cells with 160 micromolar/L Z-VAD-FMK for 30 minutes, 80 
micromolar /L present during coincubation. Values are 
means of three independent experiments. Error bars, SD. 
(From reference 8, with permission.)Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S58
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Model of hepatic NK cell-mediated tumor cell killing Figure 3
Model of hepatic NK cell-mediated tumor cell killing. For explanation: see text. The blocked FasL pathway is indicated in gray. 
Dashed lines indicate hypothetical relations. FADD, Fas-associated death domain factor; FasL, Fas ligand; LFA-1, leukocyte func-
tion associated molecule-1; G, granzyme B; HA-R, hyaluronan receptor; ICAM-1, intercellular adhesion molecule-1; M6P-R, 
mannose 6 phosphate receptor (cation-independent); P, perforin; PI-9, protease inhibitor 9; S, serglycin; sFas, soluble Fas. 
(From reference 8, with permission.)Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S58
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NK cells induce apoptosis in P815 targets. Chelation of
extracellular Ca2+ with EGTA (5 mmol/L), a treatment
known to block granule exocytosis and the action of per-
forin [10], completely abolished DNA fragmentation and
51Cr release (Fig. 2). Preincubation of the effector cells
with DCI (50 micromolar for 30 minutes), an inhibitor of
granzymes in intact cells [11,12], completely inhibited
DNA fragmentation and substantially blocked 51Cr
release (Fig. 2). Consistent with previous reports [13,14],
the general caspase inhibitor Z-VAD-FMK abrogated DNA
fragmentation but 51Cr release was unaffected (Fig. 2).
These results clearly demonstrate that P815 cells are exclu-
sively killed by the granule pathway, whereas other cyto-
toxic lymphocytes can use both the FasL and perforin/
granzyme pathway to kill this target [15-17].
We showed that hepatic NK cells and LSECs, which are in
contact with the hepatic NK cells, are strongly positive for
the granzyme B inhibitor, serine protease inhibitor PI-9/
SPI-6, and that expression of this inhibitor in target cells
results in complete resistance to hepatic NK cell-induced
apoptosis [8]. Based on these results, we put forward fol-
lowing model for hepatic NK cell-mediated killing (Figure
3): When a tumor cell enters a liver sinusoid, it is mechan-
ically trapped and/or adheres to LSECs. Hepatic NK cells
adhere to tumor cells by adhesion molecules like LFA-1.
sFas produced by hepatocytes blocks FasL on the hepatic
NK cells, preventing possible harmful effects on the FasL-
sensitive LSECs and hepatocytes. On the other hand,
highly expressed perforin and granzyme B, as a complex
with serglycin as a scaffold [18], are released by granule
exocytosis in the space formed between the NK-tumor
conjugate. Damaging of other cells (e.g. hepatocytes)
caused by leakage of granzyme B/perforin is prevented by
the very efficient endocytic uptake of the granzyme B/ser-
glycin/perforin complex by the HA-R expressed on LSECs
[19]. LSECs are protected from the action of granzyme B
by strong expression of the granzyme B inhibitor PI-9/SPI-
6 [8]. Granzyme B, presumably taken up by the M6P-R
[20], induces apoptosis in the tumor cell by activating the
caspase cascade. On the other hand, cytolysis (51Cr
release) is induced by a caspase-independent mechanism.
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